HISTOLOGICAL-CHANGES IN SMALL-BOWEL MUCOSA INDUCED BY GLIADIN SENSITIVE T-LYMPHOCYTES CAN BE BLOCKED BY ANTIINTERFERON-GAMMA ANTIBODY

被引:99
作者
PRZEMIOSLO, RT
LUNDIN, KEA
SOLLID, LM
NELUFER, J
CICLITIRA, PJ
机构
[1] UNITED MED & DENT SCH,ST THOMAS HOSP,GASTROENTEROL UNIT,LONDON SE1 7EH,ENGLAND
[2] UNIV OSLO,N-0316 OSLO,NORWAY
[3] UNIV OSLO,NATL HOSP,DEPT TRANSPLANTAT IMMUNOL,N-0027 OSLO,NORWAY
关键词
GLIADIN SENSITIVE T CELLS; CELIAC DISEASE INTERFERON GAMMA;
D O I
10.1136/gut.36.6.874
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The isolation of gliadin specific HLA-DQ2 restricted T lymphocyte clones from the intestinal mucosa of patients with coeliac disease supports a role for cell mediated immunity in the pathogenesis of this condition. Whether supernatants from immune activated T cell clones could produce histological damage to duodenal mucosa in vitro was studied. Biopsy specimens were obtained from 18 patients without coeliac disease or any demonstrable abnormality. The was maintained in organ culture for 24 hours with organ culture medium alone, with supernatant from gliadin sensitive T cell clones that had (B) or had not (A) been stimulated with gluten, and compared with the effects caused by the addition of interferon gamma to the organ culture medium. Both the (B) supernatants (1:100) and interferon gamma (100 IU/ml) produced a significant reduction in the enterocyte height (21.5 (3.4) mu m and 21.0 (3.2) mu m respectively, each p<0.001) compared with specimens grown in organ culture medium alone (27.3 (2.8) mu m). The toxic effects of (B) supernatants could be blocked by pre-incubating them with anti-interferon gamma antibody. These findings support the role of gliadin sensitive T lymphocytes in the immune pathogenesis of coeliac disease and their secretion of interferon gamma may cause the damage to enterocytes observed in this condition.
引用
收藏
页码:874 / 879
页数:6
相关论文
共 29 条
[1]  
ADAMSON G, 1993, TOXICOL APPL PHARM, V114, P100
[2]  
BENZEEV A, 1989, CELL SHAPE DETERMINA, P95
[3]   ORGAN CULTURE OF MUCOSAL BIOPSIES OF HUMAN SMALL INTESTINE [J].
BROWNING, TH ;
TRIER, JS .
JOURNAL OF CLINICAL INVESTIGATION, 1969, 48 (08) :1423-+
[4]  
DEEM RL, 1991, CLIN EXP IMMUNOL, V83, P79
[5]  
FLUGE G, 1981, SCAND J GASTROENTERO, V16, P555
[6]   GROWTH-INHIBITION OF A COLONIC ADENOCARCINOMA CELL-LINE (HT29) BY T-CELLS SPECIFIC FOR MUTANT P21 RAS [J].
GEDDEDAHL, T ;
NILSEN, E ;
THORSBY, E ;
GAUDERNACK, G .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 38 (02) :127-134
[7]   CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS [J].
GLUCKSBERG, H ;
STORB, R ;
FEFER, A ;
BUCKNER, CD ;
NEIMAN, PE ;
CLIFT, RA ;
LERNER, KG ;
THOMAS, ED .
TRANSPLANTATION, 1974, 18 (04) :295-304
[8]  
GRAU GE, 1989, SCHWEIZ MED WSCHR, V119, P1756
[9]   GUT INJURY IN MOUSE GRAFT-VERSUS-HOST REACTION - STUDY OF ITS OCCURRENCE AND MECHANISMS [J].
GUYGRAND, D ;
VASSALLI, P .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (05) :1584-1595
[10]  
HALL M, 1991, COELIAC DISEASE 40 Y, P35